Literature DB >> 1325517

Platelet Na(+)-H+ exchanger activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity.

D Rosskopf1, G Siffert, U Osswald, K Witte, R Düsing, J W Akkerman, W Siffert.   

Abstract

OBJECTIVE: Primary hypertension has been reported to be associated with an enhancement of Na(+)-H+ exchange. However, details of the kinetic properties of the Na(+)-H+ exchanger in hypertensives and its dependence upon age and gender in normotensives are unknown. PARTICIPANTS: We determined the activity of the platelet Na(+)-H+ exchanger in 20 normotensives and 26 untreated primary hypertensives.
INTERVENTIONS: In eight hypertensive individuals antihypertensive treatment was interrupted for 1 week. Treatment for 6 weeks with a daily single dose of 10 mg enalapril decreased mean arterial pressure to 105.7 +/- 11.6 mmHg.
METHODS: Platelets were loaded with the intracellular pH (pHi) indicator 2'-7'-bis-carboxyethyl-5(6)-carboxyfluorescein (BCECF) and acidified by propionic acid. Initial velocities of pH recovery were determined and used for calculation of maximum velocity (Vmax), baseline pHi and the pHi value for half maximal activation (pH0.5) of the Na(+)-H+ exchanger in each individual.
RESULTS: In normotensives, Vmax averaged 0.05 +/- 0.01 dpHi/min independently of age, gender and actual diastolic blood pressure. In hypertensives, two different subgroups were defined bearing either low or high Na(+)-H+ exchange activity. Values of pHi and pH0.5 were identical in all subgroups irrespective of Vmax. The twofold enhancement of Na(+)-H+ exchange in the second group was preserved in thrombin-stimulated platelets. Vmax values remained unaffected by enalapril treatment.
CONCLUSIONS: Enhanced Na(+)-H+ exchange activity in hypertensives is primarily characterized by an increase in Vmax. This enhancement is refractory to antihypertensive treatment and therefore appears to be a relatively fixed parameter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325517

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Correlation between human platelet cytoplasmic membrane outer leaflet fluidity, Na+/H+ exchanger activity and aging.

Authors:  C F Marinho; J Costa-Maia; J Pinto-de-Barros; C R Oliveira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 2.  Sodium-hydrogen exchange and platelet function.

Authors:  D Rosskopf
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  Na+/H+ exchange in human lymphocytes and platelets in chronic and subacute metabolic acidosis.

Authors:  H P Reusch; R Reusch; D Rosskopf; W Siffert; J F Mann; F C Luft
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Volumes and Na+/H+ antiporter activity of lymphocytes in patients with congestive heart failure.

Authors:  M Christ; V Klauss; W Pliml; K Theisen; M Wehling
Journal:  Clin Investig       Date:  1994-12

5.  Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension.

Authors:  D Rosskopf; E Frömter; W Siffert
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.

Authors:  R Düsing; M Sorger; L Mattes; B O Göbel; G Hoffmann; D Rosskopf; H Vetter; W Siffert
Journal:  Clin Investig       Date:  1993-02

7.  Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

Authors:  W Siffert; D Rosskopf; A Moritz; T Wieland; S Kaldenberg-Stasch; N Kettler; K Hartung; S Beckmann; K H Jakobs
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.